<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="iso-abbrev">CNS Neurosci Ther</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1755-5949</journal-id>
<journal-id journal-id-type="publisher-id">CNS</journal-id>
<journal-title-group>
<journal-title>CNS Neuroscience &amp; Therapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1755-5930</issn>
<issn pub-type="epub">1755-5949</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28884977</article-id>
<article-id pub-id-type="pmc">6492716</article-id>
<article-id pub-id-type="doi">10.1111/cns.12754</article-id>
<article-id pub-id-type="publisher-id">CNS12754</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Organoid technology for brain and therapeutics research</article-title>
<alt-title alt-title-type="left-running-head">WANG et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="cns12754-cr-0001">
<name>
<surname>Wang</surname>
<given-names>Zhi</given-names>
</name>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12754-cr-0002">
<name>
<surname>Wang</surname>
<given-names>Shu‐Na</given-names>
</name>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12754-cr-0003">
<name>
<surname>Xu</surname>
<given-names>Tian‐Ying</given-names>
</name>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12754-cr-0004">
<name>
<surname>Miao</surname>
<given-names>Zhu‐Wei</given-names>
</name>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="cns12754-cr-0005">
<name>
<surname>Su</surname>
<given-names>Ding‐Feng</given-names>
</name>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="cns12754-cr-0006">
<name>
<surname>Miao</surname>
<given-names>Chao‐Yu</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8176-3434</contrib-id>
<address>
<email>cymiao@smmu.edu.cn</email>
</address>
<xref ref-type="aff" rid="cns12754-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="cns12754-aff-0002">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="cns12754-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pharmacology</named-content>
<institution>Second Military Medical University</institution>
<named-content content-type="city">Shanghai</named-content>
<country country="CN">China</country>
</aff>
<aff id="cns12754-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Center of Stroke</named-content>
<institution>Beijing Institute for Brain Disorders</institution>
<named-content content-type="city">Beijing</named-content>
<country country="CN">China</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Chao‐Yu Miao, Department of Pharmacology, Second Military Medical University, Shanghai, China.<break></break>
Email: <email>cymiao@smmu.edu.cn</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2017</year>
</pub-date>
<volume>23</volume>
<issue>10</issue>
<issue-id pub-id-type="doi">10.1111/cns.2017.23.issue-10</issue-id>
<fpage>771</fpage>
<lpage>778</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>7</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>11</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>8</month>
<year>2017</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2017 John Wiley & Sons Ltd <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2017 John Wiley &amp; Sons Ltd</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:CNS-23-771.pdf" xlink:type="simple"></self-uri>
<abstract id="cns12754-abs-0001">
<title>Summary</title>
<p>Brain is one of the most complex organs in human. The current brain research is mainly based on the animal models and traditional cell culture. However, the inherent species differences between humans and animals as well as the gap between organ level and cell level make it difficult to study human brain development and associated disorders through traditional technologies. Recently, the brain organoids derived from pluripotent stem cells have been reported to recapitulate many key features of human brain in vivo, for example recapitulating the zone of putative outer radial glia cells. Brain organoids offer a new platform for scientists to study brain development, neurological diseases, drug discovery and personalized medicine, regenerative medicine, and so on. Here, we discuss the progress, applications, advantages, limitations, and prospects of brain organoid technology in neurosciences and related therapeutics.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="cns12754-kwd-0001">brain organoid</kwd>
<kwd id="cns12754-kwd-0002">drug discovery</kwd>
<kwd id="cns12754-kwd-0003">neurosciences</kwd>
<kwd id="cns12754-kwd-0004">pluripotent stem cell</kwd>
<kwd id="cns12754-kwd-0005">regenerative medicine</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>81373414</award-id>
</award-group>
<award-group>
<funding-source>Military Medicine Major Project of PLA</funding-source>
<award-id>16CXZ009</award-id>
</award-group>
<award-group>
<funding-source>Shanghai Projects</funding-source>
<award-id>16140904500</award-id>
<award-id>16431901400</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<page-count count="8"></page-count>
<word-count count="6014"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>cns12754</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>October 2017</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:02.05.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="cns12754-cit-1001" publication-type="journal">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S‐N</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>T‐Y</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>Z‐W</given-names>
</string-name>, <string-name>
<surname>Su</surname>
<given-names>D‐F</given-names>
</string-name>, <string-name>
<surname>Miao</surname>
<given-names>C‐Y</given-names>
</string-name>. <article-title>Organoid technology for brain and therapeutics research</article-title>. <source xml:lang="en"/>CNS Neurosci Ther. <year>2017</year>;<volume>23</volume>:<fpage>771</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1111/cns.12754</pub-id>
<pub-id pub-id-type="pmid">28884977</pub-id></mixed-citation>
</p>
<fn-group id="cns12754-ntgp-0001">
<fn fn-type="equal" id="cns12754-note-1001">
<p>The first two authors contributed equally to this work.</p>
</fn>
</fn-group>
</notes>
</front>
</article>
</pmc-articleset>